{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T12:08:07Z","timestamp":1788782887991,"version":"build-2803163510"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Medicine Reviews"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.tmrv.2026.151008","type":"journal-article","created":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T14:28:59Z","timestamp":1780842539000},"page":"151008","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Assessment of CTLA-4, LAG-3, and TIM-3 Expression in Pediatric Patients With \u03b2-Thalassemia Major and Their Association With Alloimmunization"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2532-7539","authenticated-orcid":false,"given":"Manal Monir","family":"Mansour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai El-Sayad","family":"Abd El-Hamid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal M.","family":"Dawoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara A.","family":"El Derbaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud M.","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmin A.H.S.","family":"Younis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tmrv.2026.151008_bib0001","doi-asserted-by":"crossref","first-page":"305","DOI":"10.4103\/mmj.mmj_232_19","article-title":"Genetic polymorphism of BCL11A (rs11886868) in Egyptian patients with \u03b2-thalassemia","volume":"34","author":"Soliman","year":"2021","journal-title":"Menoufia Med J"},{"issue":"12","key":"10.1016\/j.tmrv.2026.151008_bib0002","doi-asserted-by":"crossref","first-page":"e1788","DOI":"10.1002\/mgg3.1788","article-title":"Current status of beta-thalassemia and its treatment strategies","volume":"9","author":"Ali","year":"2021","journal-title":"Mol Genet Genomic Med"},{"key":"10.1016\/j.tmrv.2026.151008_bib0003","doi-asserted-by":"crossref","DOI":"10.3389\/frhem.2023.1187681","article-title":"Global burden and unmet needs in the treatment of transfusion-dependent \u03b2-thalassemia","volume":"2","author":"Forni","year":"2023","journal-title":"Front Hematol"},{"key":"10.1016\/j.tmrv.2026.151008_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2019.100588","article-title":"Challenges of blood transfusions in \u03b2-thalassemia","volume":"37","author":"Shah","year":"2019","journal-title":"Blood Rev"},{"key":"10.1016\/j.tmrv.2026.151008_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2023.148022","article-title":"Global distribution of \u03b2-thalassemia mutations: an update","volume":"896","author":"Rao","year":"2024","journal-title":"Gene"},{"key":"10.1016\/j.tmrv.2026.151008_bib0006","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.880752","article-title":"New insights into pathophysiology of \u03b2-thalassemia","volume":"9","author":"Sanchez-Villalobos","year":"2022","journal-title":"Front Med"},{"issue":"1","key":"10.1016\/j.tmrv.2026.151008_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2024.102911","article-title":"Thalassemia and iron overload cardiomyopathy : pathophysiological insights, clinical implications, and management strategies","volume":"50","author":"Ansharullah","year":"2025","journal-title":"Curr Probl Cardiol"},{"issue":"3","key":"10.1016\/j.tmrv.2026.151008_bib0008","article-title":"Iron overload in non-transfusion-dependent thalassemia- experience at a tertiary care center in India","volume":"10","author":"Sharma","year":"2025","journal-title":"Pediatr Hematol Oncol J"},{"issue":"1","key":"10.1016\/j.tmrv.2026.151008_bib0009","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1182\/bloodadvances.2025017090","article-title":"Short- and long-term effects of transfusion in \u03b2-thalassemia: a longitudinal study of transfusion efficiency factors","volume":"10","author":"Theocharaki","year":"2026","journal-title":"Blood Adv"},{"key":"10.1016\/j.tmrv.2026.151008_bib0010","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/3239960","article-title":"Red blood cell alloimmunization and autoimmunization in blood transfusion-dependent sickle cell disease and \u03b2 -thalassemia patients in Al-Ahsa Region, Saudi Arabia","volume":"2023","author":"Kuriri","year":"2023","journal-title":"Anemia"},{"issue":"1","key":"10.1016\/j.tmrv.2026.151008_bib0011","first-page":"4","article-title":"Red blood cell alloimmunisation in transfusion-dependent thalassaemia: a systematic review","volume":"17","author":"Franchini","year":"2019","journal-title":"Blood Transfus"},{"key":"10.1016\/j.tmrv.2026.151008_bib0012","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.phoj.2024.06.002","article-title":"Alloimmunization and autoimmunization among multitransfused thalassemia and sickle cell disease patients","volume":"9","author":"Pahuja","year":"2024","journal-title":"Pediatr Hematol Oncol J"},{"issue":"17","key":"10.1016\/j.tmrv.2026.151008_bib0013","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1182\/blood-2018-08-833962","article-title":"Transfusion-related red blood cell alloantibodies: induction and consequences","volume":"133","author":"Tormey","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2026.151008_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2023.102283","article-title":"Immune checkpoint receptors in autoimmunity","volume":"80","author":"Burke","year":"2023","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.tmrv.2026.151008_bib0015","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1198365","article-title":"Current understanding of CTLA-4: from mechanism to autoimmune diseases","volume":"14","author":"Hossen","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.tmrv.2026.151008_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2019.101305","article-title":"Lymphocyte-activation gene 3 (LAG3): the next immune checkpoint receptor HHS public access","volume":"42","author":"Ruffo","year":"2019","journal-title":"Semin Immunol"},{"issue":"2","key":"10.1016\/j.tmrv.2026.151008_bib0017","doi-asserted-by":"crossref","first-page":"89","DOI":"10.36401\/JIPO-23-4","article-title":"T cell immunoglobulin and mucin domain containing protein 3 (TIM-3) inhibitors in oncology clinical trials: a review","volume":"7","author":"Duong","year":"2024","journal-title":"J Immunother Precis Oncol"},{"issue":"23","key":"10.1016\/j.tmrv.2026.151008_bib0018","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1182\/blood-2016-07-730135","article-title":"Reduced PU.1 expression underlies aberrant neutrophil maturation and function in b-Thalassemia mice and patients","volume":"129","author":"Siwaponanan","year":"2017","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.tmrv.2026.151008_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2025.104305","article-title":"The case for universal leukoreduction of blood transfusions","volume":"65","author":"Tong","year":"2026","journal-title":"Transfus Apher Sci"},{"issue":"4","key":"10.1016\/j.tmrv.2026.151008_bib0020","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.18632\/oncotarget.23136","article-title":"Transfusion-associated adverse reactions (TAARs) and cytokine accumulations in the stored blood components : the impact of prestorage versus poststorage leukoreduction","volume":"9","author":"Chang","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.tmrv.2026.151008_bib0021","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s13643-024-02615-z","article-title":"Effect of post \u2011 storage filters vs . pre \u2011 storage filters for leukoreduction of blood components on clinical outcomes : a systematic review and meta \u2011 analysis","volume":"13","author":"da Silva","year":"2024","journal-title":"Syst Rev"},{"issue":"3","key":"10.1016\/j.tmrv.2026.151008_bib0022","doi-asserted-by":"crossref","DOI":"10.1177\/0300060519892386","article-title":"Interference in the indirect antiglobulin test and direct antiglobulin test from rheumatoid factor","volume":"48","author":"Xu","year":"2019","journal-title":"J Int Med Res"},{"key":"10.1016\/j.tmrv.2026.151008_bib0023","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1186\/s13104-024-06960-z","article-title":"Evaluation of the analytical performance of four different manufacturer\u2019s reagent red blood cells in antibody detection and identification","volume":"17","author":"Guglielmino","year":"2024","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.tmrv.2026.151008_bib0024","doi-asserted-by":"crossref","DOI":"10.1177\/20406207221100648","article-title":"Expression of \u03b3 -globin genes in \u03b2 -thalassemia patients treated with sirolimus\u202f: results from a pilot clinical trial (Sirthalaclin)","volume":"13","author":"Zuccato","year":"2022","journal-title":"Ther Adv Hematol"},{"issue":"3","key":"10.1016\/j.tmrv.2026.151008_bib0025","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/jha2.923","article-title":"Alpha globin gene alterations modifying the phenotype of homozygous beta thalassaemia","volume":"5","author":"Shaw","year":"2024","journal-title":"EJHaem"},{"key":"10.1016\/j.tmrv.2026.151008_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2025.110712","article-title":"Optimizing RT-qPCR for sex-specific analysis of iron-induced retinal gene expression","volume":"262","author":"Calafat","year":"2026","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.tmrv.2026.151008_bib0027","doi-asserted-by":"crossref","first-page":"9677","DOI":"10.3390\/ijms22189677","article-title":"Pathomechanisms of immunological disturbances in \u03b2 -thalassemia","volume":"22","author":"Gluba-Brz\u00f3zka","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.tmrv.2026.151008_bib0028","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-78333-y","article-title":"A study of red blood cell alloimmunization and autoimmunization among 200 multitransfused Egyptian \u03b2 thalassemia patients","volume":"10","author":"El-Beshlawy","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.tmrv.2026.151008_bib0029","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.883733","article-title":"Co-inhibitory molecules \u2013 Their role in health and autoimmunity\u202f; highlighted by immune related adverse events","volume":"13","author":"Greisen","year":"2022","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.tmrv.2026.151008_bib0030","doi-asserted-by":"crossref","first-page":"123","DOI":"10.37897\/RJMP.2025.2.2","article-title":"Assessment of hematological and immune parameters in patients with \u03b2-thalassemia","volume":"20","author":"Shahad","year":"2025","journal-title":"Rom J Med Pract"},{"issue":"3","key":"10.1016\/j.tmrv.2026.151008_bib0031","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2174\/1871530317666161107160213","article-title":"Immune status \u2018in children with beta thalassemia\u2019 in correlation \u2018with iron overload\u2019: single center Egyptian study","volume":"16","author":"Hagag","year":"2016","journal-title":"Endocr Metab Immune Disord Targets"},{"issue":"1","key":"10.1016\/j.tmrv.2026.151008_bib0032","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.transci.2015.03.006","article-title":"Red blood cells alloimmunization and autoimmunization among transfusion-dependent beta-thalassemia patients in Alexandria province","volume":"53","author":"Obaid","year":"2015","journal-title":"Egypt Transfus Apher Sci"},{"issue":"10","key":"10.1016\/j.tmrv.2026.151008_bib0033","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1007\/s00277-021-04605-w","article-title":"Expression of the immune checkpoint receptors CTLA-4, LAG-3, and TIM-3 in \u03b2-thalassemia major patients: correlation with alloantibody production and regulatory T cells (Tregs) phenotype","volume":"100","author":"Shokrgozar","year":"2021","journal-title":"Ann Hematol"},{"issue":"3","key":"10.1016\/j.tmrv.2026.151008_bib0034","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/s41577-019-0224-6","article-title":"TIM3 comes of age as an inhibitory receptor","volume":"20","author":"Wolf","year":"2020","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.tmrv.2026.151008_bib0035","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1007\/s12672-025-02673-2","article-title":"Unraveling the immunomodulatory role of TIM-3 in head and neck squamous cell carcinoma: implications for targeted therapy","volume":"16","author":"Xu","year":"2025","journal-title":"Discov Oncol"},{"key":"10.1016\/j.tmrv.2026.151008_bib0036","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1677581","article-title":"Research progress in RBC alloimmunization","volume":"16","author":"Fu","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.tmrv.2026.151008_bib0037","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.3389\/fimmu.2017.01215","article-title":"Coinhibitory receptor expression and immune checkpoint blockade: maintaining a balance in CD8+ T cell responses to chronic viral infections and cancer","volume":"8","author":"Okoye","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.tmrv.2026.151008_bib0038","doi-asserted-by":"crossref","DOI":"10.1155\/jimr\/5006201","article-title":"Immune tolerance regulation is critical to Immune homeostasis","volume":"2025","author":"Han","year":"2025","journal-title":"J Immunol Res"},{"key":"10.1016\/j.tmrv.2026.151008_bib0039","article-title":"Expression of immune checkpoints LAG-3, CTLA-4, TIM-3 and PD-1 in Beta thalassemia patients treated using HbF augmentation therapy and regular transfusions","author":"Khan","year":"20264318","journal-title":"Turk J Haematol"},{"issue":"12","key":"10.1016\/j.tmrv.2026.151008_bib0040","doi-asserted-by":"crossref","first-page":"981","DOI":"10.3345\/cep.2025.01046","article-title":"Assessment of natural killer cell subpopulations in pediatric patients with transfusion-dependent \u03b2-thalassemia major","volume":"68","author":"Elbassal","year":"2025","journal-title":"Clin Exp Pediatr"},{"issue":"9","key":"10.1016\/j.tmrv.2026.151008_bib0041","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.25046","article-title":"Effects of splenectomy on natural killer cell levels in \u03b2-thalassemia major patients","volume":"38","author":"Kurto\u011flu","year":"2024","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.tmrv.2026.151008_bib0042","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/3577334","article-title":"Tim-3 is differentially expressed during cell activation and interacts with the LSP-1 protein in human macrophages","volume":"2023","author":"Oca\u00f1a-Guzman","year":"2023","journal-title":"J Immunol Res"},{"issue":"15","key":"10.1016\/j.tmrv.2026.151008_bib0043","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1182\/blood.2024024230","article-title":"Mitigation of checkpoint inhibitor\u2013induced autoimmune hemolytic anemia through modulation of purinergic signaling","volume":"144","author":"Zotti","year":"2024","journal-title":"Blood"}],"container-title":["Transfusion Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887796326000490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887796326000490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T11:17:19Z","timestamp":1788779839000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887796326000490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0887796326000490"],"URL":"https:\/\/doi.org\/10.1016\/j.tmrv.2026.151008","relation":{},"ISSN":["0887-7963"],"issn-type":[{"value":"0887-7963","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of CTLA-4, LAG-3, and TIM-3 Expression in Pediatric Patients With \u03b2-Thalassemia Major and Their Association With Alloimmunization","name":"articletitle","label":"Article Title"},{"value":"Transfusion Medicine Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tmrv.2026.151008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"151008"}}